These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 6762978

  • 1. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P.
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract] [Full Text] [Related]

  • 2. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L.
    Ned Tijdschr Geneeskd; 1983 Apr 16; 127(16):673-9. PubMed ID: 6134240
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR, Doub PH, Doub NH.
    Thromb Haemost; 1976 Feb 29; 35(1):49-56. PubMed ID: 785688
    [Abstract] [Full Text] [Related]

  • 4. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Schröder R.
    Dtsch Med Wochenschr; 1981 Apr 24; 106(17):546-53. PubMed ID: 6111439
    [No Abstract] [Full Text] [Related]

  • 5. [The platelet inhibitor problem].
    Straub PW.
    Schweiz Med Wochenschr; 1981 Apr 04; 111(14):478-82. PubMed ID: 7015489
    [Abstract] [Full Text] [Related]

  • 6. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H.
    Z Arztl Fortbild (Jena); 1985 Apr 04; 79(11):463-6. PubMed ID: 3901541
    [No Abstract] [Full Text] [Related]

  • 7. Secondary prevention of myocardial infarction.
    Davies JA.
    Int J Clin Pharmacol Res; 1985 Apr 04; 5(5):303-7. PubMed ID: 3905632
    [Abstract] [Full Text] [Related]

  • 8. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M.
    Clin Ter; 1979 Oct 31; 91(2):117-27. PubMed ID: 396098
    [No Abstract] [Full Text] [Related]

  • 9. Aspirin and recurrent myocardial infarction.
    Jones RJ.
    JAMA; 1980 Aug 15; 244(7):667-8. PubMed ID: 6993715
    [No Abstract] [Full Text] [Related]

  • 10. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H.
    Acta Med Austriaca Suppl; 1982 Aug 15; 25():55-61. PubMed ID: 6958157
    [No Abstract] [Full Text] [Related]

  • 11. Platelet aggregation and atherosclerosis.
    Valladares BK, Lemberg L.
    Heart Lung; 1986 Mar 15; 15(2):211-4. PubMed ID: 3633253
    [Abstract] [Full Text] [Related]

  • 12. [Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
    Schöndorf TH.
    Med Welt; 1982 Jun 11; 33(23):851-4. PubMed ID: 7050615
    [No Abstract] [Full Text] [Related]

  • 13. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG.
    J Mal Vasc; 1983 Jun 11; 8(1):17-22. PubMed ID: 6341494
    [Abstract] [Full Text] [Related]

  • 14. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G.
    Minerva Cardioangiol; 1980 Oct 11; 28(10):723-6. PubMed ID: 7465066
    [No Abstract] [Full Text] [Related]

  • 15. Antiplatelet drugs after myocardial infarction.
    Med Lett Drugs Ther; 1980 Mar 21; 22(6):25-6. PubMed ID: 7360108
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA.
    Aust N Z J Med; 1981 Dec 21; 11(6):673-7. PubMed ID: 7036973
    [Abstract] [Full Text] [Related]

  • 18. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
    Mannucci PM.
    G Ital Cardiol; 1983 Nov 21; 13(11):335-9. PubMed ID: 6667821
    [No Abstract] [Full Text] [Related]

  • 19. Clinical aspects of antiplatelet therapy.
    Sherry S.
    Semin Hematol; 1985 Apr 21; 22(2):125-34. PubMed ID: 3890191
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R.
    Z Arztl Fortbild (Jena); 1984 Apr 21; 78(5):167-71. PubMed ID: 6202068
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.